Are you ready to learn how to uncover what Tuft’s describes as a possible “net benefit of up to 5x the upfront investment required in phase II studies, and up to 13x greater in phase III?”
For a limited time only, Medable is offering a free Certification in Decentralized Clinical Trial (DCT) through our Master Class.
In this class, Medable Senior Vice President of Partnerships, Jared Klingeisen and Director of Business Development, Mike Eckrote will discuss the emergence of the DCT market and best practices for implementing digital strategies on your next study. Clinical teams will gain valuable knowledge and strategies to improve patient enrollment, engagement and retention and reduce overall delivery timelines and costs. In taking the DCT Master Class, you will gain:
Learn from the No. 1 DCT provider in the industry!
Jared Klingeisen is Senior Vice President of Partner DCT Enablement Strategy.
Mike Eckrote is a Director of Business Development at Medable.